Company / CapEx per Share
Haemonetics CapEx per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.78
FY2024
5-year range
$0.74 / $3.72
FY2020-FY2024
Trend
+5.0%
vs FY2023
Sector context
#72 of 142
Health Care
What the data says
At $0.78, Haemonetics's capex per share ranks #72 of 142 in the Health Care sector. CapEx per Share has fluctuated over the past 9 years, ranging from $0.72 in FY2020 to $3.72 in FY2022.
Based on SEC 10-K filings.
0.78 in FY2024 with a 5-year CAGR of -3.7%.
Declined from $3.72 to $0.78 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -25.5%
- 5-Year CAGR
- -3.7%
- 10-Year CAGR
- -
Sector benchmark
#72 of 142 in Health CareTop 51% of 142This company $0.78 Sector average $1.70
▼
-54.1% below sector average
Key checks
Key Insights
- In FY2024, capex per share increased 5.0% year-over-year.
- Ranks #72 out of 142 companies in the Health Care sector.
- Peak capex per share was recorded in FY2022.
- Lowest capex per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.78 | +5.0% |
| FY2023 | $0.74 | -80.1% |
| FY2022 | $3.72 | +98.0% |
| FY2021 | $1.88 | +160.2% |
| FY2020 | $0.72 | -23.3% |
| FY2019 | $0.94 | -58.7% |
| FY2018 | $2.28 | +55.0% |
| FY2017 | $1.47 | -0.3% |
| FY2016 | $1.47 | -25.1% |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026